# Antibody–drug conjugates for cancer therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/antibody-drug-conjugates-for-cancer-therapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Anish Thomas,Beverly A. Teicher,Raffit Hassan |
| Citations | 595 |
| DOI | 10.1016/s1470-2045(16)30030-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/6601617 |
| OpenAlex ID | https://openalex.org/W2417431203 |
| PMID | 27299281 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Anish Thomas](https://scholariq.org/researchers/anish-thomas/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.